Cyclacel Pharmaceuticals Inc (CYCC)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Spiro Rombotis
Employees:
14
200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ 07922
908-517-7330

Cyclacel Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders. Its lead candidate, sapacitabine, oral nucleoside analogue prodrug that acts through a novel mechanism. It also develops Seliciclib and CYC065-Second Generation CDK Inhibitor. The company was founded by Ronald J. Berenson, David Philip Lane and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Data derived from most recent annual or quarterly report
Market Cap 29.919 Million Shares Outstanding9.234 Million Avg 30-day Volume 106.015 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.54
Price to Revenue0.0 Debt to Equity0.0 EBITDA-12.33 Million
Price to Book Value1.3664 Operating Margin0.0 Enterprise Value17.878 Million
Current Ratio18.205 EPS Growth0.816 Quick Ratio17.236
1 Yr BETA 1.7584 52-week High/Low 11.42 / 3.23 Profit Margin0.0
Operating Cash Flow Growth-1.4352 Altman Z-Score0.7877 Free Cash Flow to Firm -7.566 Million
View SEC Filings from CYCC instead.

View recent insider trading info

Funds Holding CYCC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CYCC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

4 Thousand total shares from 1 transactions

Open Market Sells (S)

12 total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BARKER SAM L

  • Director
3,374 2021-11-30 3

ROMBOTIS SPIRO GEORGE PRESIDENT AND CEO

  • Officer
  • Director
4,988 2021-11-18 2

HENNEY CHRISTOPHER S

  • Director
7,122 2021-06-15 1

SCHWARTZ BRIAN

  • Director
21,366 2021-06-15 3

SEMS LLOYD

  • Director
7,122 2021-06-15 1

HRADSKY GREGORY T.

  • Director
7,122 2021-06-15 1

SPIEGEL ROBERT J.

  • Director
7,122 2021-06-15 1

WALKER KARIN L

  • Director
21,366 2021-06-15 1

MCBARRON PAUL SEE REMARKS

  • Officer
  • Director
0 2020-12-11 1

KIRSCHBAUM MARK CHIEF MEDICAL OFFICER

  • Officer
0 2020-10-23 0

EASTERN CAPITAL LTD

PORTFOLIO SERVICES LTD.

DART KENNETH BRYAN

  • 10% Owner
No longer subject to file 2020-04-24 0

CHIAO JUDY V.P., CLIN. DEV. & REG. AFF.

  • Officer
0 2019-12-05 0

UPRICHARD DAVID C

  • Director
0 2019-05-29 0

BANHAM JOHN MICHAEL MIDDLECOTT

  • Director
0 2019-05-29 0

TANG KEVIN C

TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL PARTNERS LP

  • 10% Owner
559,900 2017-02-23 0

BACOPOULOS NICHOLAS G

  • Director
0 2016-05-26 0

SPIEGELMAN DANIEL K

  • Director
0 2012-05-23 0

SOSNOWSKI ROBERT EDWARD VP, MARKETING & SALES

  • Officer
28,000 2011-12-06 0

MARXE AUSTIN W & GREENHOUSE DAVID M

  • 10% Owner
No longer subject to file 2011-09-22 0

MORGAN STANLEY

  • 10% Owner
No longer subject to file 2009-11-10 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2008-11-18 0

WOMELSDORF DR JOHN FRANCIS VP, BUSINESS DEVELOPMENT

  • Officer
0 2008-11-18 0

COLLINS WILLIAM GENERAL MANAGER

  • Officer
0 2008-04-04 0

MCVIE JOHN GORDON

  • Director
0 2008-02-19 0

LEGAULT PIERRE

  • Director
0 2008-02-19 0

REYES GREGORY SENIOR VP, RESEARCH

  • Officer
3,000 2007-12-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BARKER SAM L - Director

2021-12-02 16:07:27 -0500 2021-11-30 S 12 $3.57 d 3,374 direct

ROMBOTIS SPIRO GEORGE - Director - Officer PRESIDENT AND CEO

2021-11-22 16:05:55 -0500 2021-11-18 P 4,000 $4.50 a 4,988 direct 2.1277 -6.9149 2.3936 3 -6.9149 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 22:15:03 UTC -7.641 7.711 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 21:45:03 UTC -7.641 7.711 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 21:15:04 UTC -7.641 7.711 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 20:45:03 UTC -7.641 7.711 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 20:15:03 UTC -7.641 7.711 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 19:45:03 UTC -7.641 7.711 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 19:15:04 UTC -7.641 7.711 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 18:45:04 UTC -7.6157 7.6857 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 18:15:03 UTC -7.6157 7.6857 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 17:45:03 UTC -7.6157 7.6857 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 17:15:03 UTC -7.6157 7.6857 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 16:45:03 UTC -7.7088 7.7788 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 16:15:04 UTC -7.7088 7.7788 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 15:45:03 UTC -7.7088 7.7788 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 15:15:03 UTC -7.7088 7.7788 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 14:45:03 UTC -8.7045 8.7745 95000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 14:15:05 UTC -8.7045 8.7745 100000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 13:45:03 UTC -8.7045 8.7745 100000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 13:15:03 UTC -8.7045 8.7745 100000
CYCLACEL PHARMACEUTICALS INC CYCC 2021-12-03 12:45:03 UTC -8.7045 8.7745 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments